Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-dia zabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dih ydro-4-oxo-3-quinoline carboxylic acid

Details for Australian Patent Application No. 2005231918 (hide)

Owner Bayer Animal Health GmbH

Inventors Benet-Buchholz, Jordi; Heep, Iris; Grunenberg, Alfons; Hallenbach, Werner; Rast, Hubert

Agent Davies Collison Cave

Pub. Number AU-B-2005231918

PCT Pub. Number WO2005/097789

Priority 10 2004 015 981.5 01.04.04 DE

Filing date 19 March 2005

Wipo publication date 20 October 2005

Acceptance publication date 12 May 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/097789 Priority application(s): WO2005/097789

13 August 2009 Assignment before Grant

  Bayer HealthCare AG The application has been assigned to Bayer Animal Health GmbH

12 May 2011 Application Accepted

  Published as AU-B-2005231918

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005231925-Highly fadeproof inks used for digital textile printing

2005231916-Oxadiazolone derivatives as PPAR delta agonists